Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- ERany/PRany/HER2+ Breast Cancer
- HER2 Positive Breast Cancer
- TN ER-/PR-/HER2- Breast Cancer
- Triple -Negative Breast Cancer
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03981705
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Todd Tuttle, MD, MS Department of Surgery, University of Minnesota
Get Well Soon